Inc. (Nasdaq:CTMX), a leader in the field of masked, conditionally activated biologics, today announced the pricing of an ...
SAB Biotherapeutics, Inc. (Nasdaq: SABS ), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and ...
New AI-assisted development approach reduces costs and accelerates delivery timelines for modern JavaScript applications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results